TapewireFind a company

person · Reporting owner

Hunt Bryan Truman

Disclosed activity across 1 company

Tapewire entity
93529
SEC CIK
0001839107

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Health Catalyst, Inc.HCAT · Entity 1565Chief Financial OfficerMarch 01, 2024March 05, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Health Catalyst, Inc.

Report date March 01, 2024 · Filed March 05, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect219,849 Reported balance After 2024-03-01 transaction · row 1
1 source row

Row 1 · 2024-03-01 · Tax withholding · Disposed 11,684 · Balance 219,849

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 5, 2024 16:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 11,684 $8.05 $94,070.22
Disclosure

SEC source: 0001562180-24-002253 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,849

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 19:33 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 11,111 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-001652 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231,533

F1 · shares: Represents an award of 11,111 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 17:39 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 14,118 $7.45 $105,183.34
Disclosure

SEC source: 0001562180-23-008137 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,422

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 20:47 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 4,128 $11.78 $48,613.39
Disclosure

SEC source: 0001562180-23-006765 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,540

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 05, 2023 Filed Jun 5, 2023 19:31 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 650 $12.00 $7,800.00
Disclosure

SEC source: 0001562180-23-004855 · primarydocument.xml · nonDerivative · entry 2

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,668

F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 on September 15, 2022.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 19:31 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 4,433 $11.24 $49,822.49
Disclosure

SEC source: 0001562180-23-004855 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239,318

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 10,925 shares held by the Reporting Person that were not previously reported due to inadvertent administrative oversight.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 16:30 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 760 $14.34 $10,898.40
Disclosure

SEC source: 0001562180-23-002570 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,826

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 17:09 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 3,351 $14.29 $47,881.10
Disclosure

SEC source: 0001562180-23-002426 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,586

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 16:10 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-001830 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,937

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Read SEC document
January 18, 2023 Filed Jan 19, 2023 17:00 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,354 $12.53 $29,503.15
Disclosure

SEC source: 0001562180-23-000515 · primarydocument.xml · nonDerivative · entry 2

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,937

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 17:00 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,055 $12.00 $24,660.00
Disclosure

SEC source: 0001562180-23-000515 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,291

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 16:38 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 9,129 $10.65 $97,221.11
Disclosure

SEC source: 0001562180-22-008051 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,346

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 16:11 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,414 $11.61 $16,409.47
Disclosure

SEC source: 0001562180-22-006492 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,475

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 17:46 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 164 $14.95 $2,452.16
Disclosure

SEC source: 0001562180-22-004815 · primarydocument.xml · nonDerivative · entry 2

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,889

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).

Read SEC document
June 01, 2022 Filed Jun 3, 2022 17:46 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 4,523 $14.24 $64,394.40
Disclosure

SEC source: 0001562180-22-004815 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,053

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 19:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 302 $26.69 $8,060.77
Disclosure

SEC source: 0001562180-22-002346 · primarydocument.xml · nonDerivative · entry 3

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,576

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4).

Read SEC document
March 01, 2022 Filed Mar 3, 2022 19:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 2,420 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002346 · primarydocument.xml · nonDerivative · entry 2

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,878

F3 · shares: Represents an award of 2,420 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 19:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,856 $26.63 $49,426.58
Disclosure

SEC source: 0001562180-22-002346 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,458

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:23 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002018 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,314

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Read SEC document
December 02, 2021 Filed Dec 7, 2021 16:13 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 4,960 $41.95 $208,059.60
Disclosure

SEC source: 0001562180-21-007529 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,314

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:58 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 957 $49.40 $47,275.80
Disclosure

SEC source: 0001562180-21-007050 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,274

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 15, 2021, in accordance with Rule 10b5-1.

Read SEC document
September 01, 2021 Filed Sep 3, 2021 16:07 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 286 $54.23 $15,510.38
Disclosure

SEC source: 0001562180-21-005803 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,231

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 19:35 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 272 $53.88 $14,654.19
Disclosure

SEC source: 0001562180-21-004062 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,517

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.66 to $54.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 19:15 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 10 $49.63 $496.28
Disclosure

SEC source: 0001562180-21-001948 · primarydocument.xml · nonDerivative · entry 2

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,789

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: Represents the weighted average sale price of the shares sold ranging from $49.17 to $49.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).

Read SEC document
March 01, 2021 Filed Mar 3, 2021 19:15 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 326 $48.60 $15,842.56
Disclosure

SEC source: 0001562180-21-001948 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,799

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $48.15 to $49.06 per share, inclusive.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 20:35 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001419 · primarydocument.xml · nonDerivative · entry 1

Hunt Bryan Truman · CIK 0001839107 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,125

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2021 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.